Galactomannan: Testing the same sample twice?

Transplant Infectious Disease

Volumn 14, Issue 4, 2012, Pages

  Furfaro, E ^a   Mikulska, M ^a   Miletich, F ^a   Viscoli, C ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; GALACTOMANNAN; PIPERACILLIN PLUS TAZOBACTAM;

ASPERGILLUS; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DRUG DEGRADATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INVASIVE ASPERGILLOSIS; LETTER; MICROBIOLOGICAL EXAMINATION; NONHUMAN; OPTICAL DENSITY; PLATELIA ASPERGILLUS TEST; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTIGENS, FUNGAL; ASPERGILLOSIS; ASPERGILLUS; HUMANS; MANNANS; REAGENT KITS, DIAGNOSTIC;

EID: 84865194257     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2012.00733.x     Document Type: Letter

References (2)

1. Oren I, Avidor I, Sprecher H. Lack of intra-laboratory reproducibility in using Platelia Aspergillus enzyme immunoassay test for detection of Aspergillus galactomanann antigen. Transpl Infect Dis 2012; 14 (1): 107-109. [Epub 2011 July 6].
2. De Pauw B, Walsh TJ, Donnelly JP, et al. European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46 (12): 1813-1821.